Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. (Q42461972)
Jump to navigation
Jump to search
scientific article published on 20 May 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. |
scientific article published on 20 May 2004 |
Statements
Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism (English)
Giorgio Bernardi
Paolo Calabresi